Table 1 Baseline characteristics
Study number | Gender | Age at operation (ranges in years) | Comorbiditiy | Operation | Postoperative complications | Age at focus group (years) | Time after operation (months) | Time after last course of CTx (months) | 8 courses of CTx received | Stoma |
|---|---|---|---|---|---|---|---|---|---|---|
FG1-R1 | Male | 65–70 | Yes | Laparascopic | No | 65–70 | 10 | 5 | No | No |
FG1-R2 | Female | 40–45 | No | Open procedure | No | 40–45 | 14 | 6 | Yes, with adjusted dose | Yes |
FG1-R3 | Male | NA | No | Conversion to open | Yes | 75–80 | NA | 4 | Yes, with adjusted dose | No |
FG1-R4 | Female | 60–65 | Yes | Laparascopic | No | 60–65 | 17 | 11 | Yes, with adjusted dose | No |
FG1-R5 | Female | 60–65 | Yes | Laparascopic | No | 60–65 | 17 | 10 | Yes, with adjusted dose | No |
FG1-R6 | Male | NA | No | Laparascopic | No | 70–75 | NA | 11 | Yes, with adjusted dose | No |
FG1-R7 | Male | 65–70 | Yes | Laparascopic | No | 65–70 | 16 | 11 | No | Yes |
FG1-R8 | Male | 60–65 | No | Laparascopic | No | 60–65 | 16 | 12 | Yes, with adjusted dose | No |
FG1-R9 | Male | 70–75 | Yes | Open procedure | Yes | 70–75 | 12 | 4 | Yes, with adjusted dose | No |
FG1-R10 | Male | 60–65 | Yes | Laparascopic | No | 60–65 | 11 | 4 | Yes | No |
FG1-R11 | Female | 30–35 | No | Conversion to open | Yes | 30–35 | 22 | 15 | Yes, with adjusted dose | No |
FG2-R1 | Female | 75–80 | Yes | Laparascopic | No | 75–80 | 8 | 2 | Yes | No |
FG2-R2 | Female | 50–55 | Yes | Laparascopic | No | 55–60 | 14 | 10 | No | No |
FG2-R3 | Male | 65–70 | No | Laparascopic | Yes | 65–70 | 16 | 9 | Yes | No |
FG2-R4 | Male | 50–55 | Yes | Laparascopic | No | 50–55 | 14 | 8 | Yes, with adjusted dose | No |
FG2-R5 | Male | 55–60 | Yes | Open procedure | No | 55–60 | 11 | 4 | No | Yes |
FG2-R6 | Female | 55–60 | No | Laparascopic | No | 55–60 | 12 | 6 | Yes, with adjusted dose | No |
FG2-R7 | Female | 65–70 | Yes | Laparascopic | No | 65–70 | 20 | 12 | No | No |
FG2-R8 | Female | 65–70 | Yes | Laparascopic | No | 65–70 | 22 | 15 | Yes, with adjusted dose | No |
FG2-R9 | Male | 60–65 | Yes | Laparascopic | No | 65–60 | 20 | 17 | No | No |
FG2-R10 | Female | 55–60 | No | Laparascopic | No | 55–60 | 15 | 9 | Yes, with adjusted dose | No |
FG2-R11 | Female | 70–75 | No | Open procedure | Yes | 70–75 | 15 | 8 | Yes | Yes |